IL4 and type 2 diabetes mellitus: In contrast, anti-inflammatory biomarkers, such as adiponectin, interleukin-4 (IL-4), and interleukin-10 (IL-10), are reported as associated with lower risk for T2D, CVD, and other cardiometabolic conditions [8,9,10,11].